Status | Study |
Not yet recruiting |
Study Name: An Initial Study of AZD7325 in Adults With Fragile X Syndrome Condition: Fragile X Syndrome Date: 2017-04-17 Interventions: Drug: AZD7325 (High-Dose) 15mg |
Recruiting |
Study Name: Single Dose Pharmacokinetic (PK) Study Condition: Angelman Syndrome Fragile X Syndrome Date: 2017-04-06 Interventions: Drug: OV101 Single-dose 5 mg OV101 Other Name: Gabox |
Recruiting |
Study Name: Rare Diseases Clinical Research Network: Neurophysiological Correlates Condition: Rett Syndrome, Preserved Speech Variant Mecp2 Duplication Syndrome Date: 2017-03-01 Interventions: Procedure: Auditory and Visual Event-related Potentials and EEG Specifically, through up to three standa |
Not yet recruiting |
Study Name: Open Label Trial of Triheptanoin (UX007) in Treatment of Rett Syndrome. Condition: Rett Syndrome Date: 2017-02-02 Interventions: Drug: Tridecanoic Acid 3 times daily oral doze of the drug for 20 weeks with 4 weeks of baseline and 4 w |
Enrolling by invitation |
Study Name: Single-Dose Acamprosate, Lovastatin, Minocycline and Placebo in Fragile X Syndrome Condition: Fragile X Syndrome Date: 2016-12-01 Interventions: Drug: Acamprosate two 666 pill |
Recruiting |
Study Name: Clinical Trial for Asses the Safety and Efficacy of Vitamin C and Vitamin E in Combination Versus Placebo for Treating Cognitive and Behavior Disorder in Children With Fragile X Syndrome Condition: X Fragile Syndrome Date: 2016-10-07 Interventions: Drug: Vitamin C 10mg/Kg Vitamin E 10 mg/Kg |
Recruiting |
Study Name: Observational Study of Males With Creatine Transporter Deficiency Condition: Creatine Deficiency, X-linked Date: 2016-10-05 |
Not yet recruiting |
Study Name: AFQ056 for Language Learning in Children With FXS Condition: Fragile X Syndrome Date: 2016-09-28 Interventions: Drug: AFQ056 Oral suspension ( |
Completed |
Study Name: New Genes Involved in Molecular Etiology of Rett Syndrome Through DNA Microarray Comparative Genomic Hybridization Condition: Rett Syndrome Date: 2016-08-23 Interventions: Procedure: Blood sampling In children: 2 EDTA tubes of 7 ml, 1 Heparin Li tube of 5 ml and 2 PAXgene tub |
Recruiting |
Study Name: Clinical Phenotyping and Characterization of Neural Networks and Cognitive Processes Involved in Mental Retardation X-linked Condition: X-linked Mental Retardation Date: 2016-06-29 Interventions: Behavioral: Neuropsychological, cognitive and behavioral assessment |